|The Moxd1 n/a (Catalog #MBS6006417) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The MOXD1 (MOX, DBH-like Monooxygenase Protein 1, Monooxygenase X) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s MOXD1 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).
Suitable for use in ELISA and Western Blot. Researchers should empirically determine the suitability of the Moxd1 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The Moxd1 n/a product has the following accession number(s) (GI #60688453) (NCBI Accession #AAH91331.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful. The amino acid sequence is listed below:
DYFTNANREL KKDAQQDYHL EYAMENSTHT IIEFTRELHT CDINDKSITD STVRVIWAYH HEDAGEAGPK YHDSNRGTKS LRLLNPEKTS VLSTALPYFD *.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Belongs to the copper type II ascorbate-dependent monooxygenase family.
Immunogen: Partial recombinant corresponding to aa21-121 from human MOXD1 (NP_056344) with GST tag. MW of the GST tag alone is 26kD. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Moxd1 are readily searchable from our website. Different antibodies against the same target such as Moxd1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.